All articles by GlobalData Healthcare

JPM26: Ypsomed commits to self-care delivery devices in new strategic plan

Ypsomed, a medical device company with a focus on self-care solutions, has announced a continued focus on delivery systems such…
JPM26: Opus Genetics builds momentum in rare retinal gene therapy

Inherited retinal diseases encompass more than 350 genetic mutations and represent a significant unmet clinical need. Opus Genetics’ portfolio approach…
JPM26: Butterfly Network aims to close the global medical imaging gap

Butterfly Network currently boasts the world’s largest installed base of point-of-care ultrasound (POCUS) devices, with its technology being utilised globally,…
JPM26: Rakuten Medical unveils transformative photoimmunotherapy platform

Rakuten Medical’s presentation at the J.P. Morgan Healthcare Conference 2026 delivered a clear message: the future of cancer care will…
JPM26: Integra resets by fixing supply and riding reimbursement tailwinds

Integra LifeSciences used its update at the ongoing 2026 J.P. Morgan Healthcare Conference in San Francisco to frame 2025 and…

JPM26: Ambu strengthens growth outlook as single-use endoscopy adoption grows

Ambu reaffirmed its long-term growth strategy focused on expanding single-use endoscopy, highlighting strong clinical adoption, improving hospital economics, and ongoing…
JPM26: Zimmer Biomet doubles down on orthopaedic robotics and specialised sales force in US

Zimmer Biomet announced plans to continue developing its robotic platforms and investing in a stronger, specialised sales force in the…
JPM26: Insulet presents optimistic growth plan heading into 2026

During the J.P. Morgan Healthcare Conference in San Francisco, Insulet highlighted that it achieved revenue growth at a compound annual…
JPM26: Danaher positioned to improve patient diagnostics

During Danaher’s company presentation at this year's J.P. Morgan Healthcare conference in San Francisco, the company highlighted the global ageing…
JPM26: Henry Schein focuses on high-margin, high-growth business as new CEO announced

Henry Schein has outlined its roadmap for 2026 which centres on improving profitability and expanding high margin businesses, at the…